- Home
- MARPS vs CLDI Comparison
MARPS vs CLDI Comparison
Compare MARPS & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARPS
- CLDI
- Stock Information
- Founded
- MARPS 1956
- CLDI 2014
- Country
- MARPS United States
- CLDI United States
- Employees
- MARPS N/A
- CLDI N/A
- Industry
- MARPS Oil & Gas Production
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MARPS Energy
- CLDI Health Care
- Exchange
- MARPS Nasdaq
- CLDI Nasdaq
- Market Cap
- MARPS 9.1M
- CLDI 9.9M
- IPO Year
- MARPS N/A
- CLDI N/A
- Fundamental
- Price
- MARPS $4.21
- CLDI $1.36
- Analyst Decision
- MARPS
- CLDI
- Analyst Count
- MARPS 0
- CLDI 0
- Target Price
- MARPS N/A
- CLDI N/A
- AVG Volume (30 Days)
- MARPS 9.2K
- CLDI 235.2K
- Earning Date
- MARPS 01-01-0001
- CLDI 11-13-2025
- Dividend Yield
- MARPS 8.57%
- CLDI N/A
- EPS Growth
- MARPS N/A
- CLDI N/A
- EPS
- MARPS 0.31
- CLDI N/A
- Revenue
- MARPS $965,040.00
- CLDI N/A
- Revenue This Year
- MARPS N/A
- CLDI N/A
- Revenue Next Year
- MARPS N/A
- CLDI N/A
- P/E Ratio
- MARPS $13.43
- CLDI N/A
- Revenue Growth
- MARPS N/A
- CLDI N/A
- 52 Week Low
- MARPS $3.34
- CLDI $1.10
- 52 Week High
- MARPS $7.90
- CLDI $27.63
- Technical
- Relative Strength Index (RSI)
- MARPS 40.89
- CLDI 38.89
- Support Level
- MARPS $4.14
- CLDI $1.29
- Resistance Level
- MARPS $4.69
- CLDI $1.56
- Average True Range (ATR)
- MARPS 0.11
- CLDI 0.13
- MACD
- MARPS -0.03
- CLDI -0.01
- Stochastic Oscillator
- MARPS 12.73
- CLDI 42.37
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.